Free Trial

Organigram (OGI) Stock Price, News & Analysis

+0.02 (+1.11%)
(As of 05/24/2024 08:50 PM ET)
Today's Range
50-Day Range
52-Week Range
670,500 shs
Average Volume
1.40 million shs
Market Capitalization
$188.13 million
P/E Ratio
Dividend Yield
Price Target
OGI stock logo

About Organigram Stock (NASDAQ:OGI)

Organigram Holdings Inc., through its subsidiaries, engages in the production and sale of cannabis and cannabis-derived products in Canada. It offers medical cannabis products, including whole flower, milled flower, pre-rolls, infused pre-rolls, vapes, gummies, and concentrates for medical retailers; adult use recreational cannabis under the SHRED, Holy Mountain, Big Bag O' Buds, Monjour, Trailblazer, SHRED'ems, Edison Cannabis Co., Edison JOLTS, Tremblant, and Laurentian brands. The company also engages in the wholesale shipping of cannabis plant cuttings, dried flowers, blends, pre-rolls, and cannabis derivative-based products to retailers and wholesalers for adult-use recreational cannabis. It sells its products through online, as well as consumer channels. The company was incorporated in 2010 and is headquartered in Toronto, Canada.

OGI Stock Price History

OGI Stock News Headlines

OrganiGram: Fiscal Q2 Earnings Snapshot
The Top 3 Cannabis Stocks to Buy in April 2024
Are Medical Stocks Lagging OrganiGram (OGI) This Year?
Why OrganiGram (OGI) Stock Is Diving
OGI Sep 2024 6.000 call
OGI Jun 2024 4.000 put
OGI Apr 2024 2.000 put
See More Headlines
Receive OGI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Organigram and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
Next Earnings (Estimated)
Fiscal Year End

Industry, Sector and Symbol

Pharmaceutical preparations
Current Symbol
Year Founded


Net Income
Net Margins
Pretax Margin


Sales & Book Value

Annual Sales
$120.01 million
Book Value
$1.95 per share


Free Float
Market Cap
$188.13 million
Investing Strategies To Help Grow Your Retirement Income Cover

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

Key Executives

  • Ms. Beena G. Goldenberg (Age 60)
    CEO & Director
    Comp: $352.27k
  • Ms. Helen Martin (Age 46)
    Chief Legal Officer & Corporate Secretary
    Comp: $223.52k
  • Mr. Timothy Emberg
    Chief Commercial Officer
  • Mr. Paolo De Luca C.A. (Age 51)
    C.F.A, Chief Strategy Officer
    Comp: $222.62k
  • Mr. Greg Guyatt C.A.
    CPA, Chief Financial Officer
  • Ms. Nathalie Batten
    Senior Vice President of Operations
  • Mr. Geoff Riggs
    Chief Information Officer
  • Max Schwartz
    Director of Investor Relations
  • Ms. Megan Amber McCrae
    Senior Vice President of Marketing & Communications
  • Ms. Katrina May McFadden
    Chief People Officer

OGI Stock Analysis - Frequently Asked Questions

Should I buy or sell Organigram stock right now?

1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Organigram in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" OGI shares.
View OGI analyst ratings
or view top-rated stocks.

How have OGI shares performed in 2024?

Organigram's stock was trading at $1.31 at the beginning of the year. Since then, OGI shares have increased by 38.9% and is now trading at $1.82.
View the best growth stocks for 2024 here

When is Organigram's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, July 11th 2024.
View our OGI earnings forecast

How were Organigram's earnings last quarter?

Organigram Holdings Inc. (NASDAQ:OGI) issued its quarterly earnings data on Tuesday, May, 14th. The company reported ($0.12) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.06) by $0.06. The firm had revenue of $27.91 million for the quarter, compared to analysts' expectations of $28.27 million. Organigram had a negative net margin of 188.38% and a negative trailing twelve-month return on equity of 40.19%.

When did Organigram's stock split?

Shares of Organigram reverse split on the morning of Friday, July 7th 2023. The 1-4 reverse split was announced on Friday, July 7th 2023. The number of shares owned by shareholders was adjusted after the market closes on Friday, July 7th 2023. An investor that had 100 shares of stock prior to the reverse split would have 25 shares after the split.

What other stocks do shareholders of Organigram own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Organigram investors own include KushCo (KSHB), Auxly Cannabis Group (CBWTF), Supreme Cannabis (SPRWF), Medical Marijuana (MJNA), CNBX Pharmaceuticals (CNBX), MariMed (MRMD), EVIO (EVIO) and

Who are Organigram's major shareholders?

Organigram's stock is owned by a number of retail and institutional investors. Top institutional shareholders include Tidal Investments LLC (1.68%), Murchinson Ltd. (0.79%), CVI Holdings LLC (0.37%) and Virtu Financial LLC (0.15%).

How do I buy shares of Organigram?

Shares of OGI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:OGI) was last updated on 5/27/2024 by Staff

From Our Partners